19Sep 24Ayobami named to PCORI’s Advisory Panel on Clinical Effectiveness and Decision Science.Read more...19Sep 24Tanawin published first author paper in Respiratory Medicine!Read more...19Sep 24Tanawin published first author paper in ERJ Open Research!Read more...19Sep 24Ayobami’s presentation of ‘temporal variation in biologics effectiveness in asthma’ wins oral talk award at EAACI, Valencia, Spain.Read more...26Feb 24Ayobami gives Plenary at the 2024 AAAAI: “Pharmacoequity in Eligibility & Access to Biologics in Patients with Asthma”.Read more...24Feb 24Tanawin showcases Drug U.S.E Lab’s research on the real-world effectiveness of the anti-TSLP agent, tezepelumab, in severe asthma.Read more... Page 1 Page 2 Next
19Sep 24Ayobami named to PCORI’s Advisory Panel on Clinical Effectiveness and Decision Science.Read more...
19Sep 24Ayobami’s presentation of ‘temporal variation in biologics effectiveness in asthma’ wins oral talk award at EAACI, Valencia, Spain.Read more...
26Feb 24Ayobami gives Plenary at the 2024 AAAAI: “Pharmacoequity in Eligibility & Access to Biologics in Patients with Asthma”.Read more...
24Feb 24Tanawin showcases Drug U.S.E Lab’s research on the real-world effectiveness of the anti-TSLP agent, tezepelumab, in severe asthma.Read more...
